Fundraising Fox

Liam Ratcliffe

InvestorFounder

Investor at Access Biotechnology · Manager at Halda Therapeutics · Board director at Arvinas Holding Co. LLC

About

Former head of worldwide clinical R&D at Pfizer, currently leading Access Biotechnology.

Manager at Halda Therapeutics

Intro paths

→

In turn, Liam can intro founders to Halda Therapeutics's investors below.

Halda Therapeutics's investors · 7

Access BiotechnologyNew York City Canaan PartnersStamford · $500K – $20M checks Connecticut InnovationsNew Haven · $500K – $2M checks Frazier Life SciencesPalo Alto RA CapitalBoston Taiho Ventures, LLCMenlo Park Vida VenturesLos Angeles

Board director at Arvinas Holding Co. LLC

Intro paths

→

In turn, Liam can intro founders to Arvinas Holding Co. LLC's investors below.

Arvinas Holding Co. LLC's investors · 9

5AM VenturesBoston · $100K – $4M checks Access BiotechnologyNew York City Canaan PartnersStamford · $500K – $20M checks · since 2015 Connecticut InnovationsNew Haven · $500K – $2M checks National Institutes of Health (NIH)since 2016 Nextech InvestZurich · $648K – $3.2M checks OrbiMedNew York · $1M – $75M checks · since 2015 RA CapitalBoston Solasta VenturesBoston

Colleagues at Access Biotechnology

Christine Borowski

Vice President at Access Biotechnology

Frequently asked questions

Who is Liam Ratcliffe?: Former head of worldwide clinical R&D at Pfizer, currently leading Access Biotechnology.
Where does Liam Ratcliffe work?: Liam Ratcliffe is at Access Biotechnology and Manager at Halda Therapeutics and Board director at Arvinas Holding Co. LLC.